Literature DB >> 8354316

Silent carrier beta-thalassaemia due to a severe beta-globin mutation interacting with other genetic elements.

D Rund1, D Filon, A Oppenheim, A Abramov.   

Abstract

Beta-thalassaemia is caused by the presence of two mutated beta-globin genes, one inherited from each parent. We describe two families in which the diagnosis of beta-thalassaemia intermedia was delayed because one of the parents, an obligatory heterozygote, had normal haematological parameters (silent carrier beta-thalassaemia). DNA analysis revealed that these silent carriers were heterozygous for a point mutation in the polyadenylation signal (AATAAA-AATAAG). This defect is known to cause a moderately severe beta-thalassaemia phenotype. In one case, concurrent deletional alpha-thalassaemia was found in the silent carrier, which may have contributed to the mild phenotype. The increasing availability of DNA analysis should allow prompt diagnosis of such cases. Silent carrier beta-thalassaemia presents a diagnostic challenge to the clinician who evaluates children with anaemia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8354316     DOI: 10.1007/bf01954083

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  13 in total

1.  Bone marrow transplantation for thalassemia and other inherited disorders of hemoglobin.

Authors:  D Weatherall
Journal:  Blood       Date:  1992-09-15       Impact factor: 22.113

2.  Mean corpuscular volume of heterozygotes for beta-thalassemia correlates with the severity of mutations.

Authors:  D Rund; D Filon; N Strauss; E A Rachmilewitz; A Oppenheim
Journal:  Blood       Date:  1992-01-01       Impact factor: 22.113

3.  Two novel polyadenylation mutations leading to beta(+)-thalassemia.

Authors:  L Jankovic; G D Efremov; G Petkov; C Kattamis; E George; K G Yang; T A Stoming; T H Huisman
Journal:  Br J Haematol       Date:  1990-05       Impact factor: 6.998

Review 4.  The thalassemia syndromes: molecular basis and prenatal diagnosis in 1990.

Authors:  H H Kazazian
Journal:  Semin Hematol       Date:  1990-07       Impact factor: 3.851

5.  The polyadenylation site mutation in the alpha-globin gene cluster.

Authors:  S L Thein; R B Wallace; L Pressley; J B Clegg; D J Weatherall; D R Higgs
Journal:  Blood       Date:  1988-02       Impact factor: 22.113

6.  A C----T substitution at nt--101 in a conserved DNA sequence of the promotor region of the beta-globin gene is associated with "silent" beta-thalassemia.

Authors:  J M Gonzalez-Redondo; T A Stoming; A Kutlar; F Kutlar; K D Lanclos; E F Howard; Y J Fei; M Aksoy; C Altay; A Gurgey
Journal:  Blood       Date:  1989-05-01       Impact factor: 22.113

7.  The silent carrier of beta thalassemia.

Authors:  E Schwartz
Journal:  N Engl J Med       Date:  1969-12-11       Impact factor: 91.245

8.  The duplicated human alpha globin genes lie close together in cellular DNA.

Authors:  S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

9.  The C-T substitution in the distal CACCC box of the beta-globin gene promoter is a common cause of silent beta thalassaemia in the Italian population.

Authors:  M S Ristaldi; S Murru; G Loudianos; L Casula; S Porcu; D Pigheddu; B Fanni; G V Sciarratta; S Agosti; M I Parodi
Journal:  Br J Haematol       Date:  1990-04       Impact factor: 6.998

10.  Evolution of a genetic disease in an ethnic isolate: beta-thalassemia in the Jews of Kurdistan.

Authors:  D Rund; T Cohen; D Filon; C E Dowling; T C Warren; I Barak; E Rachmilewitz; H H Kazazian; A Oppenheim
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

View more
  1 in total

1.  Patterns of variant polyadenylation signal usage in human genes.

Authors:  E Beaudoing; S Freier; J R Wyatt; J M Claverie; D Gautheret
Journal:  Genome Res       Date:  2000-07       Impact factor: 9.043

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.